Single dose of 50 mg/kg clofibrate in jaundice of healthy term neonates: Randomised clinical trial of efficacy and safety

Indian Journal of Pediatrics

Volumn 79, Issue 2, 2012, Pages 194-197

  Fallah, Razieh ^a   Islami, Zia ^a   Lotfi, Saeid Reza ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clofibrate; Hyperbilirubinemia; Jaundice; Neonate

Indexed keywords

BILIRUBIN; CLOFIBRATE; HEMOGLOBIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; BIRTH WEIGHT; CONTROLLED STUDY; DELIVERY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; IRAN; LENGTH OF STAY; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN JAUNDICE; PARALLEL DESIGN; PATIENT SELECTION; PHOTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; TREATMENT DURATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL;

CLOFIBRATE; FEMALE; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; MALE; SINGLE-BLIND METHOD;

EID: 84861514961     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-011-0531-9     Document Type: Article

References (20)

1. Chen J, Sadakata M, Ishida M, Sekizuka N, Sayama M. Baby massage ameliorates neonatal jaundice in full-term newborn infants. Tohoku J Exp Med. 2011;223:97-102.
2. Shapiro SM. Chronic bilirubin encephalopathy: diagnosis and outcome. Semin Fetal Neonatal Med. 2010;15:157-63.
3. Hankø E, Hansen TW, Almaas R, Lindstad J, Rootwelt T. Bilirubin induces apoptosis and necrosis in human NT2-N neurons. Pediatr Res. 2005;57:179.
4. Bhutani VK, Maisels MJ, Stark AR, Buonocore G. Expert Committee for Severe Neonatal Hyperbilirubinemia;European Society for Pediatric Research; American Academy of Pediatrics. Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants > or = 35 weeks gestation. Neonatology. 2008;94:63-7.
5. Cuperus FJ, Hafkamp AM, Hulzebos CV, Verkade HJ. Pharmacological therapies for unconjugated hyperbilirubinemia. Curr Pharm Des. 2009;15:2927-38.
6. Dennery PA. Pharmacological interventions for the treatment of neonatal jaundice. Semin Neonatol. 2002;7:111-9. (Pubitemid 34983061)
7. Sakha SH, Gharehbaghi MM, Rahbani ME. The effect of clofibrate with phototherapy in late pre-term newborns with nonhemolytic jaundice. Indian J Med Sci. 2009;63:174-9.
8. Zahedpasha Y, Ahmadpour-Kacho M, Hajiahmadi M, Naderi S, Kamali AA. Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial). Southeast Asian J Trop Med Public Health. 2008;39:557-61.
9. Eghbalian F, Pourhossein A, Zandevakili H. Effect of clofibrate in non-hemolytic indirect hyperbiliru-binemia in full term neonates. Indian J Pediatr. 2007;74:1003-6. (Pubitemid 350243606)
10. Zahedpasha Y, Ahmadpour-Kacho M, Hajiahmadi M, Naderi S. Effect of clofibrate in jaundiced full-term infants: a randomized clinical trial. Arch Iran Med. 2007;10:349-53. (Pubitemid 47162533)
11. Mohammadzadeh A, Farhat ASh, Iranpour R. Effect of clofibrate in jaundiced term newborns. Indian J Pediatr. 2005;72:123-6. (Pubitemid 40380004)
12. Badeli HR, Sharafi R, Sajedi SA. The effect of clofibrate on neonatal hyperbilirubinemia in uncomplicated jaundice. Iran J Ped. 2008;18:20-4. (Pubitemid 351663778)
13. Caballero Noguez B, Hernadez PS, Rodriguez JBE, et al. Clofibrate effect associated with phototherapy on bilirubin concentration in newly-born babies. Rev Mex Pediatr. 2001;68: 176-80.
14. Lindenbaum A, Delaporte B, Benattar C, Dehan M, Magny JF, Gerbet D, et al. Preventive treatment of jaundice in premature newborn infants with clofibrate. Double-blind controlled therapeutic trial. Arch Fr Pediatr. 1985;42:759-63.
15. Lindenbaum A, Hernandorena X, Vial M, et al. Clofibrate for the treatment of hyperbilirubinemia in neonates born at term: a double blind controlled study. Arch Fr Pediatr. 1981;38:867-73. Article in French. (Pubitemid 12102393)
16. Bourget P, Broise I, Quinquis-Desmaris V, Gabilan JC. Pharmacokinetics of clofibrate in jaundiced newborn infants at term. Arch Pediatr. 1995;2:722-8. Article in French.
17. Huang MJ, Kua KE, Teng KS, Weng HW, Huang CS. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res. 2004; 56:677-8.
18. Moslehi MA, Pishva N. Determination of effect of low dose vs moderate dose clofibrate on decreasing serum bilirubin in healthy term neonates. Iran J Ped. 2007;17:108-12.
19. Wazir S, Angiti RR, Kumar P. Effect of clofibrate in jaundiced term neonates. Indian J Pediatr. 2006;73:170. (Pubitemid 44317737)
20. Gabilan JC. Pharmacologic treatment of neonatal jaundice. A new approach. Arch Pediatr. 1998;5:1274-8. (Pubitemid 28531214)